Atlas Trials

Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease

Clinical trial NCT00742716 · COMPLETED

Trial details

NCT number
NCT00742716
Sponsor
OPKO IP Holdings II, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal InsufficiencyChronic Renal Failure
Start date
2008-10-01
Primary completion
2010-02-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.